19th Cambridge Medicinal Chemistry Symposium

September 10-13, 2017
Cambridge, UK

This conference aims to attract academic and industrial scientists engaged in all aspects of the drug discovery and development process. It aims to showcase first disclosures of significant new therapeutic agents across all disease areas, and provide a forum for discussion of current topics and thinking at the forefront of medicinal chemistry.

Charles Mowbray, Discovery Director at DNDi, presented on neglected tropical diseases.

 

Neglected tropical diseases

First disclosure of a new oral development candidate for the treatment of visceral and cutaneous leishmaniasis
Charles Mowbray, Discovery Director, DNDi

 

 

More information: